Skip to content

Discontinued — last reported Q4 '21

Geographic · Operating Income

Americas Orthopedics — Operating Income

Zimmer Biomet Holdings Americas Orthopedics — Operating Income increased by 7.7% to $454.6M in Q4 2021 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ4 2021Feb 25, 2022
Rolls up toOperating Income

How to read this metric

Higher operating income suggests strong pricing power and effective cost control, whereas a decline may indicate rising manufacturing or distribution costs within the region.

Detailed definition

This metric measures the profitability of the Americas Orthopedics segment by subtracting operating expenses from the se...

Peer comparison

Comparable to segment-level operating profit margins reported by diversified healthcare and medical technology firms.

Metric ID: zbh_segment_americas_orthopedics_operating_income_loss

Historical Data

3 periods
 Q2 '21Q3 '21Q4 '21
Value$445.4M$422.2M$454.6M
QoQ Change-5.2%+7.7%
Range$422.2M$454.6M

Frequently Asked Questions

What is Zimmer Biomet Holdings's americas orthopedics — operating income?
Zimmer Biomet Holdings (ZBH) reported americas orthopedics — operating income of $454.6M in Q4 2021.
What does americas orthopedics — operating income mean?
The profit or loss generated by the Americas Orthopedics business segment after accounting for direct operating costs.